Mednet Logo
SpecialtiesRadiation Oncology
Radiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

When, if ever, would you cover the clinically uninvolved contralateral oropharynx when treating a well-lateralized oropharyngeal cancer of the head and neck?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of Michigan

The main concern regarding another occult primary in the contralateral OPC is whether or not the ca is smoking/alcohol-related, in which case field cancerization is common and there is a risk of secondary HNC. This risk is much less in HPV+ with little smoking. A SEER study from 1975-2006 found that...

Is it safe to treat a recurrent esophageal SCC with definitive chemoradiation after a prior endoscopic mucosal resection?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of North Carolina at Chapel Hill

I would not be concerned about perforation or fistula formation. With an EMR, the resection takes off the mucosa/submucosa and leaves the wall intact. There should be sufficient time from the prior procedure to have full mucosal regrowth and the wall integrity should be well maintained.

When is pelvic lymph node dissection indicated in vulvar cancers?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

GOG 37 established adjuvant RT to pelvis and groins better than PLND for inguinal node positive patients. Pelvic recurrence rates were similar in both arm with the predominant difference being in inguinal recurrence. PLND as part of routine management in vulvar ca is hardly indicated.

Do you contour the abdominal para-aortic nodes in your elective CTVnodes for T3N1 adenocarcinoma of the GEJ getting preop chemoRT?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Brigham and Women's Hospital

A related question was also asked: Do you include subcarinal, AP window, and mediastinal paraaortic nodes in your CTV for esophageal cancer? Although I am very respectful of the time and effort that goes into writing treatment guidelines, and I frequently consult them in my own practice, it is worth...

Do you include subcarinal, AP window, and mediastinal paraaortic nodes in your CTV for esophageal cancer?

1
1 Answers

Mednet Member
Mednet Member
Radiation Oncology · University of North Carolina at Chapel Hill

Unfortunately, this is essentially a data free zone. There are certainly no clinical trials to answer the question - it is hard enough to prove the value of radiation therapy without going into second order effects such as on the exact size of the RT field. I personally do not extend the fields prox...

How would you manage a patient with Stage IVB DLBCL with refractory disease in the retroperitoneum and spleen after 6 cycles of RCHOP?

1
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Duke University Medical Center

The management of primary refractory stage IV DLBCL is complex and generally not successful. See NCCN Guidelines for details. I would distinguish, however, between those patients who are clinically refractory and those who have clinically responded well but may have residual disease by imaging, i.e....

Do you recommend elective nodal irradiation when treating unresectable pancreatic adenocarcinoma?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · UT Southwestern Medical Center

Yes. For consolidative radiotherapy following chemotherapy, we have been treating the majority of our patients with SBRT. Off trial, we treat the GTV and tumor vessel interface to 40 Gy/5 fractions via simultaneous integrated boost. The elective nodal volume (pancreatic, porta hepatis, para-aortic -...

Would you consider just treating radiographic residual disease (as opposed to all original sites of disease involvement, per ILROG guidelines) in a patient with bulky early-stage Hodgkin's lymphoma of the mediastinum?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Virginia Commonwealth University Health System

If the patient is treated with > 4 cycles of chemotherapy and the disease is considered chemo-refractory, and if dose constraints to critical structures especially to the lungs can be achieved, I would recommend treating all the original sites of disease involvement, then add boost to the residual s...

When would you recommend postmastectomy radiation to a male, status post mastectomy with 1/1 sentinel nodes with ITCs?

1
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Upfront ITC is not an indication for PMRT unless indicated for T factor. ITC after chemo, would treat like node-positive with PMRT.

When would you recommend radiation therapy for an asymptomatic pathologic fracture in a vertebral body?

1
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Virginia Commonwealth University Medical Center

I agree with Dr. @Dr. First Last. What you may be describing here is the finding of an incidental bone metastasis in a preexisting osteoporotic fracture, since bones that fracture due to cancer are generally extensively infiltrated by tumor, and in my experience these are often not painless. However...